Quest Diagnostics launches monkeypox virus testing

By LabPulse.com staff writers

July 13, 2022 -- Quest Diagnostics on Wednesday announced the availability of a lab-developed molecular diagnostic test to aid in the diagnosis of infection with the monkeypox virus.

The service will be available nationwide, with the exception of New York state, where Quest anticipates it will be available later if the New York Department of Health approves the laboratory-developed test.

Quest noted that its dual-target real-time PCR test aids in the qualitative detection and differentiation of monkeypox virus (West African clade) DNA from other non-variola orthopoxviruses.

Developed by the company's research and development team, the test was validated under CLIA federal regulations and is being performed at the company's laboratory in San Juan Capistrano, Calif.

The firm said it will be able to perform approximately 30,000 tests a week by the end of July. Quest added that it has plans to launch the U.S. Center for Disease Control and Prevention's (CDC's) orthopoxvirus test in the first half of August.

Physicians can order the Quest Diagnostics lab test beginning today and the CDC orthopoxvirus test in the first half of August.

Mayo Clinic Laboratories launches CDC monkeypox test
Mayo Clinic Laboratories announced Monday that it can begin testing for monkeypox using the U.S. Centers for Disease Control and Prevention's (CDC's)...
Labcorp launches CDC monkeypox test
Labcorp on Wednesday announced it will begin testing for monkeypox using the U.S. Centers for Disease Control and Prevention’s (CDC) orthopoxvirus assay,...
Cepheid, BioGX developing monkeypox molecular test
Cepheid and BioGX announced on Monday that they are developing a monkeypox PCR test for the Cepheid GeneXpert system.
Eurofins develops monkeypox PCR assay
Eurofins Technologies has developed a new multiplex real-time polymerase chain reaction (RT-PCR) assay for the detection of the monkeypox virus and its...
CerTest, BD to partner on monkeypox test
CerTest Biotec and Becton Dickinson (BD) have announced that they will develop a molecular diagnostic test for the monkeypox virus.
Laboratories stand ready if needed for monkeypox threat
It remains to be seen whether the much-covered monkeypox scare will turn out to be a significant crisis, a moderate concern of the likes of Zika, or just...

Copyright © 2022 LabPulse.com

Last Updated mp 7/13/2022 8:35:03 AM